Editorial: Interactions of nanoparticles with and within living organisms-What can we learn to improve efficacy of nanomedicine?

Front Mol Biosci. 2022 Oct 18:9:1044063. doi: 10.3389/fmolb.2022.1044063. eCollection 2022.

N Helge Meyer¹, Claudia Corbo^{2

3}, Guillermo R Castro^{4

5}, Goran Stjepanovic⁶, Giada G Genchi⁷, Valerio Marino⁸

¹ Department of Human Medicine, University Hospital of General and Visceral Surgery, University of Oldenburg, Milan, Italy.
² Center for Nanomedicine NANOMIB, Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.
³ IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
⁴ Max Planck Laboratory for Structural Biology, Chemistry and Molecular Biophysics of Rosario (MPLbioR,UNR-MPIbpC), Partner Laboratory of the Max Planck Institute for Biophysical Chemistry (MPIbpC,MPG), Center for Interdisciplinary Studies (CEI-CONICET), National University of Rosario, Rosario, Argentina.
⁵ Nanomedicine Nucleus, Center for Natural and Human Sciences, Federal University of ABC, Santo André, Brazil.
⁶ School of Medicine, Kobilka Institute of Innovative Drug Discovery, The Chinese University of Hong Kong, Shenzhen, China.
⁷ Smart Bio-Interfaces, Center for Materials Interfaces, Istituto Italiano di Tecnologia, Pontedera, Italy.
⁸ Section of Biological Chemistry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

No abstract available

Keywords: NMR; cancer immunotherapy; green synthesis; nanomedicine; nanoparticles; nanosuspensions; pancreatic cancer; targeted delivery.

Publication types